Antares Therapeutics
Series A
€177M
Total Raised
€177M
Investors
Abingworth, Atlas Venture, Biotechnology Value Fund +8 more
Insights
In the biopharma and biotechnology sectors, Antares Therapeutics focuses on developing transformational medicines that target validated cancer indications and other serious diseases. The company covers the spectrum from early discovery research to work with manufacturing teams as candidate therapies move toward clinical testing. Its pipeline reflects a multidisciplinary approach in life science development. Backing from Abingworth, Atlas Venture and Lightspeed Venture Partners among others underscores confidence in its strategy.
Careers at Antares Therapeutics
Jun 13Sr. Scientist/Principal Scientist, Translational Research and Clinical Biomarkers (Immunology)
Antares TherapeuticsMay 12Director, Financial Planning & Analysis (Biotech Experience Necessary)
Antares TherapeuticsSimilar Companies
JumpArtificial Intelligence (AI), Financial Services, FinTech, Generative AI, SaaS, Wealth Management · Salt Lake City, Utah, United States, North America
OuttakeArtificial Intelligence (AI), Cyber Security, Machine Learning · Brooklyn, New York, United States, North America
GoodfireArtificial Intelligence (AI), Generative AI, Information Technology · San Francisco, California, United States, North America
Northwood SpaceAerospace, Hardware, Satellite Communication · Torrance, California, United States, North America
ZocksArtificial Intelligence (AI), Enterprise Software, Financial Services, Software · San Francisco, California, United States, North America
VulnCheckArtificial Intelligence (AI), Cyber Security, Information Technology, Network Security · Lexington, Massachusetts, United States, North America